BENCHMARKING THE IMPACT OF HTA ON NEW MEDICINES DEVELOPMENT AND COVERAGE DECISION MAKING

被引：1
|
作者：
Wang, T. [1 ]
机构：
[1] CIRS, London, England
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.478
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP84
引用
收藏
页码：A798 / A798
页数：1
相关论文
共 50 条
  • [21] THE EFFECT OF EUNETHTA ASSESSMENTS ON NATIONAL HTA DECISION MAKING
    Chew, V. C.
    Sogokon, P.
    McNamara, L.
    Morrison, S.
    VALUE IN HEALTH, 2018, 21 : S212 - S212
  • [22] PERCEPTIONS ON THE PHARMACISTS' ROLE IN HTA DECISION MAKING IN GREECE
    Naoum, V
    Naoum, P.
    Karampli, E.
    Athanasakis, K.
    Kyriopoulos, J.
    Pavi, E.
    VALUE IN HEALTH, 2019, 22 : S805 - S805
  • [23] HIERARCHY OF CLINICAL ENDPOINTS IN HTA DECISION MAKING IN ONCOLOGY
    Kreeftmeijer, J.
    Ryan, J.
    Van Engen, A.
    Heemstra, L.
    VALUE IN HEALTH, 2015, 18 (03) : A220 - A220
  • [24] ENVIRONMENTAL SUSTAINABILITY IN HTA: ARE HTA BODIES APPLYING ENVIRONMENTAL CRITERIA IN THEIR DECISION-MAKING?
    Szawara, P.
    Chu, J.
    Lekhwar, P.
    Dimitrova, L.
    Wagner, P.
    Van Engen, A.
    Ramachandran, K.
    VALUE IN HEALTH, 2023, 26 (12) : S376 - S376
  • [25] PHARMAC decision-making on new medicines. A case study
    Davis, Peter
    JOURNAL OF PRIMARY HEALTH CARE, 2022, 14 (01) : 4 - 5
  • [26] THE IMPACT OF NEW MEDICINES DEVELOPMENT ON PHARMACEUTICAL ANALYSIS
    WIBLIN, CN
    HAMBLETON, P
    MELLING, J
    SCAWEN, M
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 : 374 - 380
  • [27] Bridging Health Technology Assessment (HTA) and Efficient Health Care Decision Making with Multicriteria Decision Analysis (MCDA): Applying the EVIDEM Framework to Medicines Appraisal
    Goetghebeur, Mireille M.
    Wagner, Monika
    Khoury, Hanane
    Levitt, Randy J.
    Erickson, Lonny J.
    Rindress, Donna
    MEDICAL DECISION MAKING, 2012, 32 (02) : 376 - 388
  • [28] VALUE ADDED MEDICINES: ADJUSTEMENTS OF HTA DECISION FRAMEWORKS TO CAPTURE THEIR FULL VALUE
    Remuzat, C.
    Toumi, M.
    VALUE IN HEALTH, 2017, 20 (09) : A705 - A706
  • [29] ANALYSIS OF STAKEHOLDERS INVOLVED IN HTA DECISION MAKING PROCESS IN THE UK
    Kalbasko, A.
    Andreykiv, M.
    Van Engen, A.
    Zorzi, O.
    VALUE IN HEALTH, 2012, 15 (07) : A278 - A278
  • [30] PERSPECTIVE USE OF HTA IN THE DECISION-MAKING PROCESS IN UKRAINE
    Piniazhko, O.
    Ilyk, R.
    Zalis'ka, O.
    Brezden, O.
    VALUE IN HEALTH, 2017, 20 (05) : A62 - A62
12345